Results 191 to 200 of about 749,609 (349)
Supplementation with mannan oligosaccharides (MOS) enhances growth, disease resistance, antioxidant capacity, and gut microbiota diversity while suppressing inflammation, apoptosis, and strengthening intestinal barrier integrity in zebrafish challenged with LPS or DSS.
Zhiyuan Lu +4 more
wiley +1 more source
: In recent decades, the digestive tract microbiota of livestock has been extensively studied, revealing associations with host phenotypes, including production- and health-related traits.
L. Brulin +10 more
doaj +1 more source
This review highlights critical “translational gaps” in understanding micro‐ and nanoplastics impacts on gastrointestinal diseases, bridging exposure, detecting, and mechanistic toxicology. Abstract Micro‐ and nanoplastics (MNPs) have become pervasive environmental contaminants with increasing evidence linking them to adverse health outcomes.
Zhenli Diao +3 more
wiley +1 more source
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen +9 more
wiley +1 more source
Fecal microbiota transplantation (FMT) is a medical procedure that allows to establish a stable and healthy intestinal microbiota in various diseases believed to be related to a gut dysbiosis.
Anna Sopel +3 more
core +1 more source
Swine fecal microbiota samples associated with the study "Highly fermentable fiber alters fecal microbiota and mitigates swine dysentery during Brachyspira hyodysenteriae challenge".
Iowa State University (17854979)
core
Exploring ways to improve CDI outcomes
Clostridium difficile is an anaerobic spore-forming Gram-positive bacillus recognized as an evolving international health problem. Metronidazole and vancomycin were - until recently - the only drugs available to treat C. difficile infection (CDI). Better
Guery, B. +3 more
core +1 more source
A probiotic spore‐based drug delivery system (BCS‐Que@ApNPs) provides excellent targeted delivery, bioresponsive drug release, and long‐term retention (over 48 h), making it suitable for oral treatment of inflammatory bowel disease and its associated anxiety and depression.
Qingling Song +9 more
wiley +1 more source
STUDY AIMS: Clostridioides difficile infection (CDI) is associated with high recurrence and mortality. Faecal microbiota transplantation (FMT) is recognised as the most effective treatment for recurrent CDI.
Keyvan Moser +6 more
doaj +1 more source
Commentary on key aspects of fecal microbiota transplantation in small animal practice
Jennifer Chaitman,1 Albert E Jergens,2 Frederic Gaschen,3 Jose F Garcia-Mazcorro,4 Stanley L Marks,5 Alicia G Marroquin-Cardona,4 Keith Richter,6 Giacomo Rossi,7 Jan S Suchodolski,8 J Scott Weese9 1Veterinary Internal Medicine and Allergy Specialists ...
Rossi G +9 more
core

